Endpoints News 生物医药· Ryan Cross·· 10 天前AI 评分35
Oyster Therapeutics 获 6000 万美元用于开发Tau蛋白降解药物
London startup raises $60M for degraders aimed at Alzheimer’s protein tau
AI 导读
Oyster Therapeutics 获得 6000 万美元融资,致力于开发针对阿尔茨海默病致病Tau蛋白的口服降解药物。
正文
Oyster Therapeutics has raised $60 million to develop pills that destroy pathogenic forms of tau, a brain protein implicated in Alzheimer’s disease.
The Series A-2 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news